bpc 157 for torn achilles BPC-157 vs. TB-500: What Patients Should Know When an Injury Won't Heal:

A final alternative to alleviate FcRn-controlled pathological mechanisms could be to alter FcRn in itself, as may be intended with a gene therapy being developed in a collaboration between Beam and Apellis for a one-time dose of gene-editing molecules targeting FcRn [436, 437]

There are no approved human or animal dosing guidelines for this product

doi:10.1136/annrheumdis-2015-208840 123Drugs and Lactation Database (LactMed)

Some individuals have a deficiency of the B12 vitamin, which can be either due to natural reasons or dietary factors

Efficacy, safety, and immunogenicity of a booster regimen of Ad26.COV2.S vaccine against COVID-19 (ENSEMBLE2): results of a randomised, double-blind, placebo-controlled, phase 3 trial